What genuinely moves to no-code, and what does not
Drawing this line precisely is what separates a no-code programme that scales from one that produces forty unmaintainable agents in a year.
| A subject-matter expert can configure | An engineer still owns |
|---|---|
| The agent's task instructions and tone | Connecting a new source system or API for the first time |
| Which approved knowledge sources it draws on | How those sources are indexed, chunked and secured |
| Which of the platform's existing tools it may call | Building a new tool, and scoping what it can reach |
| The review and escalation steps | Identity integration and role mapping |
| Test cases drawn from real work | The evaluation harness those cases run in |
| Requesting promotion to production | Change control, versioning and rollback |
Read the right-hand column carefully: it is almost entirely security and lifecycle work. That is the argument for a platform rather than a standalone no-code tool — the engineering column is built once, centrally, and every no-code agent inherits it.
Why healthcare raises the bar
General-purpose no-code agent builders assume the builder may connect the agent to whatever data they can reach. In a health system that assumption is unsafe, because the builder's own access is frequently broader than the agent's should be.
- Agent access is not builder access. An agent must be scoped to the minimum data its function requires, independently of the permissions of whoever configured it.
- PHI leaves a trail the builder cannot see. Prompts, retrieved context and outputs all become records subject to retention and audit. See HIPAA-compliant generative AI.
- Errors have a review obligation. A no-code agent that drafts clinical or billing content needs a defined human checkpoint before its output takes effect.
- Estate risk compounds. Forty agents built by forty people, each with its own data reach, is a governance problem long before it is a cost problem.
No-code should widen who can express a workflow, not widen what the platform will let an agent reach. Access scoping, logging and change control stay centralised and are never configurable from inside the no-code surface.
How this works on InferAgents
Dev Studio — the development interface of InferAgents — is where agents are built. It presents a configuration surface to subject-matter experts while the platform enforces the controls underneath.
- Start from an approved template for the agent category — retrieval, drafting, checking or triage — each already carrying its review and logging behaviour.
- Select knowledge sources from those an engineering team has already connected, indexed and secured. Nothing new is reachable by selection alone.
- Choose tools from the platform catalogue. Each tool's data reach was scoped when it was built, not when it was selected.
- Pick or inherit a model. Because the platform is model-agnostic, this is a configuration choice rather than an architectural one.
- Test against real cases in the platform's evaluation harness, with results recorded.
- Request promotion. An engineering owner approves the move to production, and the agent enters normal change control.
The result at University of Chicago Medicine is that the health system's own IT organisation builds directly on the platform, with clinical and operational staff contributing the domain configuration rather than filing requirements and waiting.
Questions to ask a no-code agent vendor
- Can a builder grant an agent access to data the builder can reach but the agent should not? If yes, the security model is inverted.
- Where is access scoping configured — in the agent, or centrally in the platform?
- What happens between a no-code build and production? If the answer is "nothing", there is no change control.
- Can we see, in one place, every agent in the estate, its owner, its data reach and its current model?
- Can an agent built without code be evaluated with a repeatable test set before promotion?
- If we change the underlying model, do no-code agents need rebuilding?
These questions, alongside the security, governance, RAG and integration criteria, are consolidated in the healthcare AI platform evaluation guide.
Frequently asked questions
What are no-code AI agents?
No-code AI agents are agents configured through a visual interface rather than by writing code. A subject-matter expert defines the agent's instructions, selects approved knowledge sources and tools, sets review steps and tests the result, while the underlying platform provides the integrations, security and lifecycle machinery.
Can clinical staff build their own AI agents?
They can configure them, which is the part that benefits most from domain expertise. What they should not control is what data an agent can reach, how sources are indexed and secured, or whether an agent reaches production. Those stay with an engineering owner, enforced by the platform rather than by policy alone.
Is no-code AI agent building secure enough for healthcare?
It is, provided the no-code surface cannot widen the platform's security boundary. Agent access scoping, audit logging, retention and change control must be enforced centrally and be unconfigurable from inside the build interface. If a builder can grant an agent access simply because they personally have it, the model is not safe for PHI.
Does no-code mean we do not need engineers?
No. It changes what engineers spend time on. Integrations, access scoping, tool development, evaluation harnesses and production change control remain engineering work. What no-code removes is engineering being the bottleneck for every wording change, knowledge-source swap or new variation of an existing agent pattern.
What is Dev Studio?
Dev Studio is the development interface of InferAgents — the environment inside the platform where agents are designed, tested and shipped. It is a component of InferAgents rather than a separate product, and it is not licensed or deployed independently.